Pregled bibliografske jedinice broj: 971292
Psychopharmacotherapy and dry eye syndrome
Psychopharmacotherapy and dry eye syndrome // Book of abstracts of the 2018 OCCSEE & EAOO Conference
Pula, Hrvatska, 2018. str. 150-150 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 971292 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Psychopharmacotherapy and dry eye syndrome
Autori
Bakija, Ivana ; Kaštelan, Snježana ; Bogadi, Marija ; Pili, Kristijan ; Filipčić, Igor
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of abstracts of the 2018 OCCSEE & EAOO Conference
/ - , 2018, 150-150
Skup
2018 Optometry Conference of Central and South-Eastern Europe (OCCSEE) & European Academy of Optometry and Optics (EAOO)
Mjesto i datum
Pula, Hrvatska, 11.05.2018. - 13.05.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
psychopharmacotherapy ; dry eye syndrome
Sažetak
Educational topic Dry eye syndrome (DES) is one of the most common ocular morbidities and often results in significant eye discomfort, visual disturbances and potential damage to the corneal surface. It is a very common eye condition which can be caused by different mechanisms, affects quality of life of large number of population and represents an important and common public health problem. Many systemic drugs have been associated with ocular and visual side effects that require ophthalmological assessment. Furthermore it is known that some drugs used in psychiatry may cause ocular drying through reduction of tear film production. Discussion DES is well-recognized adverse side effect of many topical and systemic medications including psychiatric drugs. In psychiatry, patients with depression, schizophrenia and other psychotic disorders, posttraumatic stress disorders (PTSD) or bipolar disorders who are taking antidepressants, antipsychotics, lithium carbonate and sodium valproate frequently experience dry eye symptoms. Many ocular side effects of psychiatric medications can only be identified with a complete ophthalmological examination which is frequently ignored by psychiatrists during the psychiatric treatment. There is an increasing awareness that incidence of ocular side effects rises rapidly with the use of polypharmacy that is very often seen in psychiatric patients and thus this fact should not be neglected. Conclusions Psychiatrists, ophthalmologists and patients need to be aware and prepared for possible medication- induced adverse effect such as dry eye during the psychiatric treatment. In order to reduce the incidence of side effects of applied medications clinicians should try to use the lowest possible dose to achieve the desired therapeutic effect. Consequently further studies regarding the potential mechanisms of psychiatric medications on the tear film function as well as ocular surface alteration are needed.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Psihijatrijska bolnica "Sveti Ivan" Zagreb